| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. | SVP, Finance | Common Stock | 119,752 | $77,012 | $0.6431 | 17 Feb 2026 | Direct |
| Tenaya Therapeutics, Inc. | SVP, Finance | Stock Option (Right to buy) | 175,500 | 03 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | 17 Feb 2026 | 3 | -$2,231 | 4 | SVP, Finance | 17 Feb 2026, 19:15 |
| TNYA | Tenaya Therapeutics, Inc. | 03 Feb 2026 | 2 | $0 | 4 | SVP, Finance | 05 Feb 2026, 18:03 |
| TNYA | Tenaya Therapeutics, Inc. | 17 Nov 2025 | 1 | -$1,818 | 4 | SVP, Finance | 17 Nov 2025, 20:34 |
| TNYA | Tenaya Therapeutics, Inc. | 18 Aug 2025 | 3 | -$3,711 | 4 | SVP, Finance | 18 Aug 2025, 21:00 |
| TNYA | Tenaya Therapeutics, Inc. | 16 May 2025 | 1 | -$615 | 4 | SVP, Finance | 16 May 2025, 19:07 |
| TNYA | Tenaya Therapeutics, Inc. | 10 Mar 2025 | 3 | -$1,336 | 4 | SVP, Finance | 10 Mar 2025, 21:44 |
| TNYA | Tenaya Therapeutics, Inc. | 06 Feb 2025 | 0 | $0 | 3 | SVP, Finance | 07 Feb 2025, 20:30 |